Cellosaurus cell line IMS-BC2 (CVCL

Cross-references
Cell line name	IMS-BC2
Accession	CVCL_A7NF
Resource Identification Initiative	To cite this cell line use: IMS-BC2 (RRID:CVCL_A7NF)
Comments	Population: Japanese. Doubling time: 36 hours (PubMed=9650450). Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Sequence variations	Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=9650450; PubMed=10071072).
Disease	Chronic myelogenous leukemia, BCR-ABL1 positive (NCIt: C3174) Chronic myeloid leukemia (ORDO: Orphanet_521)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell	Male
Age at sampling	50Y
Category	Cancer cell line
Publications	PubMed=9650450; DOI=10.1016/s0925-5710(98)00007-3 Nagamura F., Nagamura-Inoue T., Tojo A., Minamihisamatsu M., Tanabe T., Zaike Y., Tani K., Saisho H., Asano S. Establishment of novel cell lines derived from two patients with chronic myelogenous leukemia in blast crisis; IMS-BC1 and IMS-BC2 which exhibit markedly different sensitivity to apoptosis. Int. J. Hematol. 67:283-294(1998) PubMed=10071072; DOI=10.1016/S0145-2126(98)00171-4 Drexler H.G., MacLeod R.A.F., Uphoff C.C. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia. Leuk. Res. 23:207-215(1999)
Encyclopedic resources	Wikidata; Q107115448
Entry history
Entry creation	20-May-2021
Last entry update	19-Dec-2024
Version number	5